Kayne Anderson Rudnick Investment Management LLC Takeda Pharmaceutical CO LTD Put Options Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $39.8 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
367Shares Held
70.8MCall Options Held
3.3MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$195 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$83.4 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$65.8 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$58.9 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$54.3 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...